Tofacitinib Coupons & Savings Card – Discount Prices from $3462.00
Generic for: Xeljanz
My prescription
Edit
10GM, Tofacitinib (1 Bottle)
Select pharmacy
CVS
$3462.00
COUPON PRICE
Rite Aid
$3477.01
COUPON PRICE
Walmart
$3614.01
COUPON PRICE
Walgreens
$3625.00
COUPON PRICETofacitinib savings card
Show this card to your pharmacistCVS
$3462.00
BIN
ID
PCN
GRP
019876
LH2417CF3D
CHIPPO
LHX
Powered by
More prescriptions for rheumatoid arthritis
More prescriptions for rheumatoid arthritis
Price history for Xeljanz (brand) & Tofacitinib (generic)
1, 10GM
Average retail price for Xeljanz
Average retail price for Tofacitinib
Average SaveHealth price for Tofacitinib
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
We analyzed Tofacitinib prices for (10GM, 1 Bottle) over the last 12 months. The average retail price was $12509.96, while the average price using the SaveHealth discount card was $3575.00. That's a savings of approximately 71.42% when using our Tofacitinib coupon.
Compared to the generic version, Xeljanz had an average price of $1146.65 over the same time period. With the SaveHealth savings card, Tofacitinib is -211.78% cheaper on average than Xeljanz.
Tofacitinib dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10GM | 1 Bottle | $3462.00 | $3462.00 |
Tofacitinib Warnings
This document outlines essential safety warnings and precautions for the use of Xeljanz (tofacitinib). It is crucial to understand these risks and discuss any concerns with your healthcare provider.
Serious Infections: Xeljanz (tofacitinib) can compromise your immune system, increasing susceptibility to serious infections like tuberculosis, shingles, and hepatitis. Regular monitoring for infections by your healthcare provider is recommended. Inform your provider immediately if you experience symptoms such as fever, chills, body aches, painful urination, or a cough. Higher risk factors include current or recurrent infections, conditions increasing infection risk, residence in or travel to TB-prevalent areas, and concurrent use of immune-suppressing medications.
Increased Mortality Risk in Rheumatoid Arthritis Patients: Individuals aged 50 or older with rheumatoid arthritis and at least one cardiovascular risk factor, taking Xeljanz (tofacitinib), showed a higher mortality rate compared to another RA treatment in a clinical study. Discuss potential risks and benefits with your provider if you fall into this category, especially if you have high blood pressure, cholesterol, or blood sugar.
Cancer Risk: Cases of cancer, such as lymphoma, lung, and skin cancer, have been reported in Xeljanz (tofacitinib) users. Regular cancer risk assessments will be conducted by your provider. Discuss any cancer concerns, particularly if you have a history of cancer or smoke.
Cardiovascular Events: Xeljanz (tofacitinib) may increase the risk of blood clots, potentially causing life-threatening events like heart attacks or strokes. This risk is higher in those aged 50 and above with cardiovascular risk factors. Talk to your provider if you have high blood pressure, cholesterol, blood sugar, a smoking history, or past blood clots.
Gastrointestinal Issues: Some patients have reported gut tears during Xeljanz (tofacitinib) treatment, though a direct causation is not established. If you use NSAIDs or have a history of diverticulitis, you may be at increased risk. Seek immediate medical help for symptoms like stomach pain or blood in stools.
Allergic Reactions: Rare but serious allergic reactions can occur. Immediate medical attention is required for symptoms such as facial or throat swelling, breathing difficulties, or rashes.
Blood Cell Count Reduction: Xeljanz (tofacitinib) can lower red and white blood cell counts, increasing the risk of anemia and infection. Regular blood tests will be conducted to monitor your blood cell levels. Report symptoms of anemia or infection, such as fatigue, headache, pale skin, rapid heartbeat, fever, chills, cough, or body aches, to your provider.
Liver Health: Elevated liver enzymes, indicating liver damage, may occur with Xeljanz (tofacitinib) use. Frequent liver function tests will be performed. Notify your provider of any signs of liver issues, such as nausea, stomach pain, or yellowing of the skin or eyes.
No specific contraindications have been identified for Xeljanz (tofacitinib). Always consult your healthcare provider for personalized advice and information.
Tofacitinib Side Effects
Common side effects:
- Upper respiratory tract infections
- Nose and throat infections
- Diarrhea
Headaches
Less common but important to monitor:
- High cholesterol
- Muscle damage
- Rash
- Stomach infections
Anemia
Serious side effects:
- Fever
- Nausea
- High blood pressure
- Any other form of infection
Tofacitinib Interactions
What is the drug tofacitinib used for?
Tofacitinib is used to treat certain autoimmune conditions, such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by modulating the immune system to reduce inflammation and alleviate symptoms associated with these conditions.
Is tofacitinib an immunosuppressant?
Yes, tofacitinib is an immunosuppressant. It is a medication that modulates the immune system and is used to treat certain autoimmune conditions by reducing inflammation.
What are the disadvantages of tofacitinib?
Tofacitinib has several potential disadvantages, including an increased risk of infections, as it can suppress the immune system. Patients may also experience elevated liver enzymes, increased cholesterol levels, and a higher risk of blood clots. There is also a potential for gastrointestinal perforations and an increased risk of certain cancers. Regular monitoring by a healthcare provider is recommended to manage these risks effectively.
Can you take Xeljanz long term?
Xeljanz (tofacitinib) can be taken long term, but it requires regular monitoring by a healthcare provider. Long-term use may be associated with certain risks, including increased risk of infections, blood clots, and other potential side effects. It is important for patients to have regular follow-ups with their healthcare provider to monitor for any adverse effects and to ensure the medication is working effectively.
What is the difference between methotrexate and tofacitinib?
Methotrexate and tofacitinib are both medications used to treat certain autoimmune conditions, but they work differently and have distinct characteristics.Methotrexate is a disease-modifying antirheumatic drug (DMARD) that works by inhibiting the metabolism of folic acid, which in turn affects the immune system and reduces inflammation. It is commonly used to treat rheumatoid arthritis, psoriasis, and certain types of cancer.Tofacitinib, on the other hand, is a Janus kinase (JAK) inhibitor. It works by interfering with the JAK-STAT signaling pathway, which plays a role in the immune response. Tofacitinib is used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.In summary, the primary difference lies in their mechanisms of action and the specific pathways they target within the immune system.